Glucose and Inflammatory Cells Decrease Adiponectin in Epicardial Adipose Tissue Cells: Paracrine Consequences on Vascular Endothelium

Journal of Cellular Physiology

Volumn 231, Issue 5, 2016, Pages 1015-1023

  Fernández Trasancos, Ángel ^a   Guerola Segura, Raquel ^b   Paradela Dobarro, Beatriz ^a   Álvarez, Ezequiel ^a   García Acuña, José María ^a,b   Fernández, Ángel Luis ^b   González Juanatey, José Ramón ^a,b   Eiras, Sonia ^a  

^a Instituto de Investigación Sanitaria de Santiago de Compostela IDIS   (Spain)

^b Pediatric Nutrition Research Group Health Research Institute of Santiago de Compostela   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; CONDITIONED MEDIUM; GLUCOSE;

ADIPOGENESIS; ADIPOSE TISSUE; AGED; CELL COMMUNICATION; CELL DIFFERENTIATION; CONDITIONED MEDIUM; DRUG EFFECTS; FEMALE; HUMAN; INFLAMMATION; MACROPHAGE; MALE; METABOLISM; PARACRINE SIGNALING; PATHOLOGY; PERICARDIUM; PHARMACOLOGY; STROMA CELL; SUBCUTANEOUS FAT; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

ADIPOGENESIS; ADIPONECTIN; ADIPOSE TISSUE; AGED; CELL COMMUNICATION; CELL DIFFERENTIATION; CULTURE MEDIA, CONDITIONED; ENDOTHELIUM, VASCULAR; FEMALE; GLUCOSE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; MACROPHAGES; MALE; PARACRINE COMMUNICATION; PERICARDIUM; STROMAL CELLS; SUBCUTANEOUS FAT;

EID: 84956610587     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.25189     Document Type: Article

References (46)

1. Antonelli A, Bianchi M, Crinelli R, Gentilini L, Magnani M. 2001. Modulation of ICAM-1 expression in ECV304 cells by macrophage-released cytokines. Blood Cells Mol Dis 27:978-991.
2. Apovian CM, Bigornia S, Mott M, Meyers MR, Ulloor J, Gagua M, McDonnell M, Hess D, Joseph L, Gokce N. 2008. Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects. Arterioscler Thromb Vasc Biol 28:1654-1659.
3. Bambace C, Sepe A, Zoico E, Telesca M, Olioso D, Venturi S, Rossi A, Corzato F, Faccioli S, Cominacini L, Santini F, Zamboni M. 2014. Inflammatory profile in subcutaneous and epicardial adipose tissue in men with and without diabetes. Heart Vessels 29:42-48.
4. Bettencourt N, Toschke AM, Leite D, Rocha J, Carvalho M, Sampaio F, Xara S, Leite-Moreira A, Nagel E, Gama V. 2011. Epicardial adipose tissue is an independent predictor of coronary atherosclerotic burden. Int J Cardiol 158:26-32.
5. Constant VA, Gagnon A, Landry A, Sorisky A. 2006. Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes. Diabetologia 49:1402-1411.
6. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS. 2001. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 107:1255-1262.
7. Chuang CC, Yang RS, Tsai KS, Ho FM, Liu SH. 2007. Hyperglycemia enhances adipogenic induction of lipid accumulation: Involvement of extracellular signal-regulated protein kinase 1/2, phosphoinositide 3-kinase/Akt, and peroxisome proliferator-activated receptor gamma signaling. Endocrinology 148:4267-4275.
8. de Luca C, Olefsky JM. 2008. Inflammation and insulin resistance. FEBS Lett 582:97-105.
9. Eiras S, Teijeira-Fernandez E, Salgado-Somoza A, Couso E, Garcia-Caballero T, Sierra J, Juanatey JR. 2010. Relationship between epicardial adipose tissue adipocyte size and MCP-1 expression. Cytokine 51:207-212.
10. Eiras S, Teijeira-Fernandez E, Shamagian LG, Fernandez AL, Vazquez-Boquete A, Gonzalez-Juanatey JR. 2008. Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue. Cytokine 43:174-180.
11. Fandino-Vaquero R, Fernandez-Trasancos A, Alvarez E, Ahmad S, Batista-Oliveira AL, Adrio B, Fernandez AL, Gonzalez-Juanatey JR, Eiras S. 2014. Orosomucoid secretion levels by epicardial adipose tissue as possible indicator of endothelial dysfunction in diabetes mellitus or inflammation in coronary artery disease. Atherosclerosis 235:281-288.
12. Fernandez-Trasancos A, Fandino-Vaquero R, Agra RM, Fernandez AL, Vinuela JE, Gonzalez-Juanatey JR, Eiras S. 2014. Impaired adipogenesis and insulin resistance in epicardial fat-mesenchymal cells from patients with cardiovascular disease. J Cell Physiol 229:1722-1730.
13. Gimble JM, Bunnell BA, Frazier T, Rowan B, Shah F, Thomas-Porch C, Wu X. 2013. Adipose-derived stromal/stem cells: A primer. Organogenesis 9:3-10.
14. Gornicka A, Fettig J, Eguchi A, Berk MP, Thapaliya S, Dixon LJ, Feldstein AE. 2012. Adipocyte hypertrophy is associated with lysosomal permeability both in vivo and in vitro: Role in adipose tissue inflammation. Am J Physiol Endocrinol Metab 303:E597-E606.
15. Greulich S, de Wiza DH, Preilowski S, Ding Z, Mueller H, Langin D, Jaquet K, Ouwens DM, Eckel J. 2012. Secretory products of guinea pig epicardial fat induce insulin resistance and impair primary adult rat cardiomyocyte function. J Cell Mol Med 15:2399-2410.
16. Grosso AF, de Oliveira SF, Higuchi Mde L, Favarato D, Dallan LA, da Luz PL. 2014. Synergistic anti-inflammatory effect: Simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome. Diabetol Metab Syndr 6:47.
17. Henninger AM, Eliasson B, Jenndahl LE, Hammarstedt A. 2014. Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes. PLoS ONE 9:e105262.
18. Hirata Y, Kurobe H, Akaike M, Chikugo F, Hori T, Bando Y, Nishio C, Higashida M, Nakaya Y, Kitagawa T, Sata M. 2011a. Enhanced inflammation in epicardial fat in patients with coronary artery disease. Int Heart J 52:139-142.
19. Hirata Y, Tabata M, Kurobe H, Motoki T, Akaike M, Nishio C, Higashida M, Mikasa H, Nakaya Y, Takanashi S, Igarashi T, Kitagawa T, Sata M. 2011b. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol 58:248-255.
20. Holm T, Damas JK, Holven K, Nordoy I, Brosstad FR, Ueland T, Wahre T, Kjekshus J, Froland SS, Eiken HG, Solum NO, Gullestad L, Nenseter M, Aukrust P. 2003. CXC-chemokines in coronary artery disease: Possible pathogenic role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells. J Thromb Haemost 1:257-262.
21. Hopkins TA, Ouchi N, Shibata R, Walsh K. 2007. Adiponectin actions in the cardiovascular system. Cardiovasc Res 74:11-18.
22. Iacobellis G, Bianco AC. 2011. Epicardial adipose tissue: Emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 22:450-457.
23. Iacobellis G, Leonetti F. 2005. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab 90:6300-6302.
24. Iacobellis G, Pistilli D, Gucciardo M, Leonetti F, Miraldi F, Brancaccio G, Gallo P, di Gioia CR. 2005. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine 29:251-255.
25. Iglesias MJ, Eiras S, Pineiro R, Lopez-Otero D, Gallego R, Fernandez AL, Lago F, Gonzalez-Juanatey JR. 2006. [Gender differences in adiponectin and leptin expression in epicardial and subcutaneous adipose tissue. Findings in patients undergoing cardiac surgery]. Rev Esp Cardiol 59:1252-1260.
26. Itoh M, Suganami T, Hachiya R, Ogawa Y. 2011. Adipose tissue remodeling as homeostatic inflammation. Int J Inflam 2011:720926.
27. Kolb H, Eizirik DL. 2011. Resistance to type 2 diabetes mellitus: A matter of hormesis? Nat Rev Endocrinol 8:183-192.
28. Libby P, Ridker PM, Maseri A. 2002. Inflammation and atherosclerosis. Circulation 105:1135-1143.
29. Lopaschuk GD. 2002. Metabolic abnormalities in the diabetic heart. Heart Fail Rev 7:149-159.
30. Mahabadi AA, Lehmann N, Kalsch H, Robens T, Bauer M, Dykun I, Budde T, Moebus S, Jockel KH, Erbel R, Mohlenkamp S. 2014. Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: Results from the Heinz Nixdorf recall study. JACC Cardiovasc Imaging 7:909-916.
31. Nahrendorf M, Keliher E, Panizzi P, Zhang H, Hembrador S, Figueiredo JL, Aikawa E, Kelly K, Libby P, Weissleder R. 2009. 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc Imaging 2:1213-1222.
32. Nedvidkova J, Smitka K, Kopsky V, Hainer V. 2005. Adiponectin, an adipocyte-derived protein. Physiol Res 54:133-140.
33. Nitta CF, Orlando RA. 2013. Crosstalk between immune cells and adipocytes requires both paracrine factors and cell contact to modify cytokine secretion. PLoS ONE 8:e77306.
34. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y. 1999. Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 100:2473-2476.
35. Reynolds AR. 2009. Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer. Dose Response 8:253-284.
36. Sacks HS, Fain JN, Cheema P, Bahouth SW, Garrett E, Wolf RY, Wolford D, Samaha J. 2011. Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: Changes associated with pioglitazone. Diabetes Care 34:730-733.
37. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746-26749.
38. Suganami T, Nishida J, Ogawa Y. 2005. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: Role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 25:2062-2068.
39. Takami S, Yamashita S, Kihara S, Kameda-Takemura K, Matsuzawa Y. 1998. High concentration of glucose induces the expression of intercellular adhesion molecule-1 in human umbilical vein endothelial cells. Atherosclerosis 138:35-41.
40. Teijeira-Fernandez E, Eiras S, Grigorian-Shamagian L, Salgado-Somoza A, Martinez-Comendador JM, Gonzalez-Juanatey JR. 2010. Diabetic and nondiabetic patients express similar adipose tissue adiponectin and leptin levels. Int J Obes (Lond) 34:1200-1208.
41. Veilleux A, Caron-Jobin M, Noel S, Laberge PY, Tchernof A. 2011. Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women. Diabetes 60:1504-1511.
42. Vilahur G, Hernandez-Vera R, Molins B, Casani L, Duran X, Padro T, Badimon L. 2009. Short-term myocardial ischemia induces cardiac modified C-reactive protein expression and proinflammatory gene (cyclo-oxygenase-2, monocyte chemoattractant protein-1, and tissue factor) upregulation in peripheral blood mononuclear cells. J Thromb Haemost 7:485-493.
43. Wang CP, Hsu HL, Hung WC, Yu TH, Chen YH, Chiu CA, Lu LF, Chung FM, Shin SJ, Lee YJ. 2009. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol (Oxf) 70:876-882.
44. Wernstedt Asterholm I, Tao C, Morley TS, Wang QA, Delgado-Lopez F, Wang ZV, Scherer PE. 2014. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab 20:103-118.
45. Wong D, Dorovini-Zis K. 1995. Expression of vascular cell adhesion molecule-1 (VCAM-1) by human brain microvessel endothelial cells in primary culture. Microvasc Res 49:325-339.
46. Yeop Han, Omer AY, Chan M, Wabitsch CK, O'Brien M, Wight KD, Chait TN. 2009. Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: Dissociation of adipocyte hypertrophy from inflammation. Diabetes 59:386-396.